Link: UCOP's e-newsletter

Stay Informed. Stay Connected.

UC BRAID welcomes new executive director

Laurie Herraiz

Laurie Herraiz, Executive Director, UC BRAID

On Thursday, July 18, Dan Cooper, director of the Institute for Clinical and Translational Science at UC Irvine, announced the appointment of Laurie Herraiz as executive director of UC Biomedical Research Acceleration, Integration and Development (UC BRAID).

UC BRAID is a coalition of the Clinical Translational Science Award (CTSA) programs at UC Davis, UC Irvine, UCLA, UC San Diego and UCSF. Formed in 2010, its goal is to accelerate research and improve health through collaboration, sharing resources and infrastructure development. UC BRAID connects researchers and administrators to solve problems, increase opportunities and create efficiency of scale while operating under shared governance. It is considered to be a model of success for harnessing the talents of CTSA hubs to advance clinical research and science.

Herraiz has 20 years of experience in clinical research and research administration at UCSF, where she most recently served as director of the UCSF Institutional Review Board (IRB). Among her many accomplishments was leading the effort to reduce approval times for clinical research. Previously, she served as a bionutritionist at the CTSA’s Clinical Research Center, where she conducted metabolic studies. During her eight years at the IRB, Herraiz collaborated on several UC BRAID initiatives and other systemwide projects.

Through her experience as a member of the UCSF Vice Chancellor’s Task Force for Clinical Trials Activation, Herraiz is skilled at assessing multiple components of the clinical trials process, as well as collaborating with fellow research administrators to develop efficiencies.

“We are delighted that Laurie has accepted this position,” says Cooper. “We look forward to working with her to collaborate across the UC system and accelerate research to improve health throughout California.”

Learn more about UC BRAID.

Tags: ,

Leave your comment here